TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | 0 | 1 | 5 | 4 | 9 | 11 | 6 |
| S | %wins | 75 | 50 | 0 | 25 | 25 | 25 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/16/12 16:04 | 8/14/12 | TECH | Techne Corp /mn/ | MN | Health | BioPrd | Biological Products, (No Diag | Veronneau Marcel | MN | O | VP Hemat | S.d | -32 | 67.57 | 10 | 0 | -1 | 41 | D | 14 | -6 | -2 | -2 | -10 | -9 | -2 | -2 | 0 | 1 | 8 | 2 | 3 | 13 |
5/31/11 11:23 | 5/26/11 | TECH | Techne Corp /mn/ | MN | Health | BioPrd | Biological Products, (No Diag | Veronneau Marcel | MN | O | VP Hemat | S.d | -41 | 81.20 | 8 | -1 | -1 | 41 | D | 40 | 37 | 35 | 14 | 10 | 4 | 0 | 1 | 0 | -3 | 2 | -13 | -23 | -13 |
11/4/10 11:08 | 11/3/10 | TECH | Techne Corp /mn/ | MN | Health | BioPrd | Biological Products, (No Diag | Veronneau Marcel | MN | O | VP Hemat | S.d | -459 | 61.08 | 5 | -8 | -15 | 41 | D | -12 | -2 | -1 | 1 | 2 | -1 | -5 | 0 | -1 | 0 | 3 | 12 | 28 | 12 |
5/3/05 15:16 | 5/2/05 | TECH | Techne Corp /mn/ | MN | Health | BioPrd | Biological Products, (No Diag | Veronneau Marcel | MN | O | Vice P - | S.d | -668 | 41.75 | 10 | -16 | -31 | 35 | D | 59 | 9 | 18 | 22 | 7 | 3 | 4 | 2 | 1 | 4 | 8 | 16 | 27 | 31 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |